New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.

Data demonstrate potent suppression of MAPK signaling and viability in KRAS mutant cell lines, as well as anti-tumor activity across multiple ...

Telomir Pharmaceuticals (TELO) reported new preclinical data from an in vivo study in mice bearing human aggressive prostate cancer tumors ...

First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating ...

Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a ...

The latest announcement is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On October 22, 2025, Telomir Pharmaceuticals announced preclinical ...

Chronic alcohol use accelerates Alzheimer’s disease (AD) progression by intensifying oxidative stress, neuroinflammation, and ...

Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are ...

Trastuzumab botidotin is a HER2-targeted ADC composed of a cytotoxic drug (Duostatin-5, anti-microtubule agent) with ...